ERO:PA:PA-SPDR MSCI Europe UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 332.63

Change

-4.94 (-1.46)%

Market Cap

USD 0.29B

Volume

425.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-10 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-1.01 (-2.22%)

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-11.50 (-2.20%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-8.35 (-2.24%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

-0.71 (-2.08%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-4.50 (-1.76%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-7.05 (-1.60%)

USD 8.85B
WLD:PA Lyxor UCITS MSCI World D-EUR

-7.06 (-2.10%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

-1.16 (-2.21%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

N/A

USD 6.91B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

+0.10 (+1.34%)

USD 5.25B

ETFs Containing ERO:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.87% 84% B 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.87% 84% B 73% C
Trailing 12 Months  
Capital Gain 11.97% 75% C 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.97% 73% C 72% C
Trailing 5 Years  
Capital Gain 86.82% 66% D+ 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 86.82% 62% D 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 12.68% 69% C- 70% C-
Dividend Return 12.68% 68% D+ 68% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.21% 56% F 77% C+
Risk Adjusted Return 103.83% 83% B 91% A-
Market Capitalization 0.29B 53% F 62% D

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike